Your browser doesn't support javascript.
loading
TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD.
Marth, Katharina; Renner, Andreas; Pohl, Wolfgang.
Affiliation
  • Marth K; Karl Landsteiner Institute for Experimental and Clinical Pneumology, Department of Pulmonary Diseases, Hietzing Hospital, Vienna, Austria. Electronic address: katharina.marth@gesundheitsverbund.at.
  • Renner A; Karl Landsteiner Institute for Experimental and Clinical Pneumology, Department of Pulmonary Diseases, Hietzing Hospital, Vienna, Austria.
  • Pohl W; Karl Landsteiner Institute for Experimental and Clinical Pneumology, Department of Pulmonary Diseases, Hietzing Hospital, Vienna, Austria.
Respir Med ; 182: 106398, 2021 06.
Article in En | MEDLINE | ID: mdl-33901786
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Beclomethasone / Pulmonary Disease, Chronic Obstructive / Formoterol Fumarate / Glycopyrrolate Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Respir Med Year: 2021 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Beclomethasone / Pulmonary Disease, Chronic Obstructive / Formoterol Fumarate / Glycopyrrolate Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Respir Med Year: 2021 Document type: Article Country of publication: Reino Unido